Paid Clinical Trials Louisiana
Discover 753 paid clinical trials in Louisiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
LetrozoleLetrozole in Uterine Leiomyosarcoma
Sponsor:
GOG Foundation
Location:
Code:
NCT05649956
Conditions
Uterine Leiomyosarcoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Letrozole
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderA Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06817356
Conditions
Alcohol Use Disorder
Eligibility Criteria
Sex: All
Age: 21 - 65
Healthy Volunteers: Not accepted
Interventions
Mazdutide
Placebo
MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Location:
Code:
NCT06431256
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 4 - 5
Healthy Volunteers: Not accepted
Interventions
HLD200 methylphenidate hydrochloride capsules
Placebo HLD200 capsules
Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT06205485
Conditions
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Leucovorin
Oxaliplatin
Fluoruracil
Capecitabine
Radiation
Hyperbaric Oxygen TherapyHyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
Sponsor:
LCMC Health
Location:
Code:
NCT06148285
Conditions
Acute Ischemic Stroke
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Hyperbaric Oxygen Therapy
Interested in new trials?
Get alerts for new trials in your area by subscribing now
OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06869785
Conditions
Relapsing Multiple Sclerosis (RMS)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ofatumumab approved dose
Ofatumumab new dose
Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry
Sponsor:
Parkinson's Foundation
Location:
Code:
NCT04994015
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lab Assay for seven genetic variants for Parkinson's Disease
MK-1167A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06721156
Conditions
Alzheimer Disease
Dementia
Eligibility Criteria
Sex: All
Age: 55 - 70+
Healthy Volunteers: Not accepted
Interventions
MK-1167
Placebo
Trappsol CycloA 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
Sponsor:
Cyclo Therapeutics, Inc.
Location:
Code:
NCT05607615
Conditions
Alzheimer's Disease
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
Hydroxypropyl Beta Cyclodextrin
Placebo
Sodium LoweringSodium Lowering Vascular Effects Trial
Sponsor:
Tulane University
Location:
Code:
NCT05388032
Conditions
Endothelial Dysfunction
Vascular Stiffness
Left Ventricular Hypertrophy
Left Ventricular Dysfunction
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Sodium Reduction Intervention